Replies to post #20311 on RespireRx Pharmaceuticals Inc (RSPI)

[RBlatch]

I am aware of that GFP, as I have had pretty much continuous contact with Roger throughout this present matter.

A company that is to be a success must have leadership that can remove obstacles that are in the way of making progress and a profit. A successful management team gets it done. It doesn't accept anything less. Especially in crucial times while fighting for your very existence.

Sometimes I think these acadmia driven coporations are so accustomed to being on the boar's tit and losing money that they don't actually have the wherewithall or vision neccessary for company success.

It is not that these people are not "nice" people. It is, though, that they are reactionaries instead of the demanding pain-in-the-ass type people we need them to be.

Cordially,
RBlatch

[enemem]

I've forgotten about cor for the last few weeks, because no news is no news, and speculation is stressful, comes at the cost of all the other things one should be thinking about, and doesn't change outcomes. I highly recommend this tactic during these down times.

That said, the tardy release of the RD-1 data is in dog-ate-the-homework territory. If we're not getting the results now because the key statistician is on vacation, then why didn't we get the results before the statistician went on vacation? These data have been in the can since mid-june, n=16. How many vacation-prone people are involved in this process? Further, if you announce "2-4 weeks" (as they did at the RD-2 unveiling) then it is implausible that you'd be blind-sided by a key individual's vacation. If cor management aren't closely following the progress of this study, then what are they doing? A vacation is not proprietary information, and at the very least could have been factored into the presented RD-1 results presentation date estimate.

At best this is bad management.